Biogen Inc. buy Vassago1
Start price
27.07.15
/
50%
€275.42
Target price
27.01.16
€306.69
Performance (%)
-14.89%
End price
27.01.16
€234.40
Summary
This prediction ended on 27.01.16 with a price of €234.40. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.89%. Vassago1 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biogen Inc. | 6.730% | 6.730% | -27.082% | -9.463% |
iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by Vassago1 for this prediction
In the thread Biogen Inc. diskutieren
NPM 36%
kurze Q3 Info:
Biogen hat Analystenerwartungen beim Umsatz u. Gewinn klar übertroffen. Die EPS Prognose wurde für das lfd. Jahr angehoben und neue Rekordumsätze bei Tecfidera, Plegridy, Alprolix, und Eloctate erzielt. NPM 35%.
http://media.biogen.com/press-release/investor-relations/biogen-third-quarter-2015-revenues-increase-11-28-billion-company-r
(Laufzeit überschritten)